Sort
50,496 grants matching “lung cancer”
Development of TIMP-2 derivatives or strategies as biologic therapies for cancer
$807,783William Stetler-Stevenson · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Systematic identification of oncogenic KRAS synthetic lethal interactions
$807,776William C Hahn · Broad Institute, Inc. · U01 · FY2017 · CA
Systematic identification of oncogenic KRAS synthetic lethal interactions
$807,776William C Hahn · Broad Institute, Inc. · U01 · FY2016 · CA
(PQ3) Addressing Cancer Treatment Disparities for Persons with HIV
$807,549Michael J Silverberg · Kaiser Foundation Research Institute · R01 · FY2025 · CA
Epigenetic Changes Link COPD and Lung Cancer
$807,435Yohannes Tesfaigzi · Lovelace Biomedical & Environmental Research Institute · R01 · FY2012 · CA
(PQ3) Addressing Cancer Treatment Disparities for Persons with HIV
$807,377Michael J Silverberg · Kaiser Foundation Research Institute · R01 · FY2021 · CA
SENTRY: STABILITY-ENHANCED TRANSCRIPTOMICS FOR EARLY LUNG CANCER DETECTION
$807,333University Of Utah · · FY2025 · Defense Health Agency
(PQ3) Addressing Cancer Treatment Disparities for Persons with HIV
$807,310Michael J Silverberg · Kaiser Foundation Research Institute · R01 · FY2023 · CA
Fred Hutchinson Breast Cancer Clinical Validation Center
$807,303Christopher I Li · Fred Hutchinson Cancer Center · U01 · FY2022 · CA
Optimizing Ultrasensitive DNA methylation detection for lung cancer and other malignancies
$807,262James G. Herman · University Of Pittsburgh At Pittsburgh · U2C · FY2025 · CA
DEVELOPMENT OF DRUG INHIBITORS OF SRC
$807,195University Of Texas Md Anderson Can Ctr · U19 · FY2000 · CA
Clonal Hematopoeisis of Indeterminate Potential and Risk of Autopsy-defined Sudden Cardiac Death
$807,158Zian H Tseng · University Of California, San Francisco · R01 · FY2023 · HL
Long Term Oral Health Outcomes in the Chronic GVHD Consortium
$806,745Nathaniel S Treister · Brigham And Women'S Hospital · R01 · FY2019 · DE
Cocoa Supplement and Multivitamin Outcomes Study in the Mind (COSMOS-Mind)
$806,500Laura D. Baker · Wake Forest University Health Sciences · R01 · FY2016 · AG
Vaccine and radiation for the therapy of human cancers
$806,457James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Vaccine and Drug Combination Therapy for Human Cancers
$806,457James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Clonal Hematopoiesis in Healthy Individuals from Families with Early OnsetCoronary Artery Disease
$806,434Lewis C Becker · Johns Hopkins University · R01 · FY2021 · HL
Host genetic predictors of plasma IL-1b levels and pharmacogenomics of in vivo IL-1b blockade during treated HIV disease
$806,398Sulggi Angela Lee · University Of California, San Francisco · R01 · FY2023 · AI
Novel Quantitative Emphysema Subtypes in MESA and SPIROMICS
$806,343R Graham Barr · Columbia University Health Sciences · R01 · FY2020 · HL
Host genetic predictors of plasma IL-1b levels and pharmacogenomics of in vivo IL-1b blockade during treated HIV disease
$806,285Sulggi Angela Lee · University Of California, San Francisco · R01 · FY2022 · AI
Host genetic predictors of plasma IL-1b levels and pharmacogenomics of in vivo IL-1b blockade during treated HIV disease
$806,131Sulggi Angela Lee · University Of California, San Francisco · R01 · FY2020 · AI
Simulating Protein Structures, Complexes, And Dynamics
$806,087Peter J Steinbach · Center For Information Technology · ZIA · FY2017 · CT
DNA Repair Capacity Assays for Lung Disease Risk Assessment
$806,066Steven A Belinsky · Lovelace Biomedical Research Institute · U01 · FY2022 · CA
Intercepting progression from pre-invasive to invasive lung adenocarcinoma
$805,881Nasser Khaled Altorki · Weill Medical Coll Of Cornell Univ · UH3 · FY2023 · CA
HARVARD COLLABORATIVE ORAL CANCER STUDY
$805,710Harvard University (Sch Of Public Hlth) · R01 · FY2001 · CA